Safety and Immunogenicity of Two Intradermal Rabies Vaccine Regimens Administered With and Without Human Rabies Immunoglobulin in Subjects ≥ 1 Years of Age
Clinical trial NCT02177032 · COMPLETED
Trial details
- NCT number
- NCT02177032
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-01
- Primary completion
- 2014-10-01
- Enrollment
- 885
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.